another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict.
fda commissioner: it�s not a secret, sir. many experts know about it..
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance...
legislation (h 2442) sponsored by braintree rep..cancel.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)..